Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics. Pichon A, Connes P, Quidu P, Marchant D, Brunet J, Levy BI, Vilar J, Safeukui I, Cymbalista F, Maignan M,Richalet JP, Favret F. Eur Respir J. 2012 Dec;40(6):1401-9.

Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion. Sebaa A, Ades L, Baran-Marzack F, Mozziconacci MJ, Penther D, Dobbelstein S, Stamatoullas A, Récher C, Prebet T, Moulessehoul S, Fenaux P, Eclache V. Genes Chromosomes Cancer. 2012 Dec;51(12):1086-92.

Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia? Cherry AM, Slovak ML, Campbell LJ, Chun K, Eclache V, Haase D, Haferlach C, Hildebrandt B, Iqbal AM, Jhanwar SC, Ohyashiki K, Sole F, Vandenberghe P, VanDyke DL, Zhang Y, Dewald GW. Leuk Res. 2012 Jul;36(7):832-40.

Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course. Put N, Van Roosbroeck K, Konings P, Meeus P, Brusselmans C, Rack K, Gervais C, Nguyen-Khac F, Chapiro E, Radford-Weiss I, Struski S, Dastugue N, Gachard N, Lefebvre C, Barin C, Eclache V, Fert-Ferrer S, Laibe S, Mozziconacci MJ, Quilichini B, Poirel HA, Wlodarska I, Hagemeijer A, Moreau Y, Vandenberghe P, Michaux L; BCGHo and the GFCH. Ann Hematol. 2012 Jun;91(6):863-73.

The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia. Le Roy C, Deglesne PA, Chevallier N, Beitar T, Eclache V, Quettier M, Boubaya M, Letestu R, Lévy V, Ajchenbaum-Cymbalista F, Varin-Blank N. Blood. 2012 Jul 12;120(2):356-65.

Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumabin previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial. Lepretre S, Aurran T, Mahé B, Cazin B, Tournilhac O, Maisonneuve H, Casasnovas O, Delmer A, Leblond V, Royer B, Corront B, Chevret S, Delépine R, Vaudaux S, Van Den Neste E, Béné MC, Letestu R, Cymbalista F, Feugier P. Blood. 2012 May 31;119(22):5104-10.

Catalase polymorphisms and metabolic diseases. Hebert-Schuster M, Fabre EE, Nivet-Antoine V. Curr Opin Clin Nutr Metab Care. 2012 Jul;15(4):397-402.